| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/24/2000 | CA2340095A1 Canine growth hormone secretagogue receptor |
| 02/24/2000 | CA2339963A1 Medium density polyethylene film having unidirectional tear |
| 02/24/2000 | CA2339817A1 Profiling and cataloging expressed protein tags |
| 02/24/2000 | CA2339779A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | CA2339575A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 02/24/2000 | CA2339518A1 Gene |
| 02/24/2000 | CA2339418A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | CA2339414A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
| 02/24/2000 | CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339350A1 High level secretory expression system of intact mk family protein |
| 02/24/2000 | CA2339338A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | CA2339337A1 Drug targets in candida albicans |
| 02/24/2000 | CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | CA2339326A1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | CA2339303A1 Methods of forming neurons |
| 02/24/2000 | CA2339302A1 Vascular endothelial growth factor 3 |
| 02/24/2000 | CA2339300A1 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2338885A1 Antimicrobial peptides isolated from the skin of american frogs |
| 02/24/2000 | CA2338386A1 Proteases and associated proteins |
| 02/24/2000 | CA2338283A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/24/2000 | CA2338184A1 Bacterial superantigen vaccines |
| 02/24/2000 | CA2338015A1 Genes for detecting bacteria and a method for detecting bacteria by using the genes |
| 02/24/2000 | CA2336733A1 Variable output applicator and method for multi-component biologic fluid agents, and application method |
| 02/24/2000 | CA2334946A1 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation |
| 02/24/2000 | CA2333832A1 Pesticidal toxins and genes from bacillus laterosporus strains |
| 02/24/2000 | CA2301201A1 Method of inhibiting cathepsin k |
| 02/24/2000 | CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus |
| 02/23/2000 | EP0980912A1 Alkaline ceramidase (E.C. 3.5.1.23) gene from Pseudomonas aeruginosa |
| 02/23/2000 | EP0980874A1 Process for production of insulin precursors having correctly linked cystein bridges |
| 02/23/2000 | EP0980439A1 Pan-bacterial and pan-fungal identification reagents and methods of use thereof |
| 02/23/2000 | EP0980435A1 Human prohormone convertase 4 |
| 02/23/2000 | EP0980434A1 Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
| 02/23/2000 | EP0980433A1 Uncoupling protein homologue: ucp 3 |
| 02/23/2000 | EP0980432A1 Chimeric opg polypeptides |
| 02/23/2000 | EP0980431A1 Antimicrobial peptide |
| 02/23/2000 | EP0980430A1 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis |
| 02/23/2000 | EP0980429A2 Human toll-like receptor proteins, related reagents and methods |
| 02/23/2000 | EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 02/23/2000 | EP0980426A1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs) |
| 02/23/2000 | EP0980390A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes |
| 02/23/2000 | EP0980389A1 Antigen |
| 02/23/2000 | EP0980388A1 Vif-derived hiv protease inhibitors |
| 02/23/2000 | EP0980387A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
| 02/23/2000 | EP0980386A2 Estrogen receptor crystals and ligands |
| 02/23/2000 | EP0980385A1 Peptides and compounds that bind to the il-5 receptor |
| 02/23/2000 | EP0980380A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 02/23/2000 | EP0980259A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 02/23/2000 | EP0980251A1 Tissue factor for influencing blood vessel formation |
| 02/23/2000 | EP0980240A1 Sustained-release compositions and method for preparing same |
| 02/23/2000 | EP0980204A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES |
| 02/23/2000 | CN1245537A Method for protecting plants |
| 02/23/2000 | CN1245536A Novel calpaines, production and use thereof |
| 02/23/2000 | CN1245534A Mammalian cell surface antigens and relating reagents |
| 02/23/2000 | CN1245533A Mammalian chemokines |
| 02/23/2000 | CN1245532A Reduction of phosphorus containing components in edible oils comprising high amount of non-hydratable phosphorus by use of phospholipase from filamentous fungus having phospholipase A and/or B activit |
| 02/23/2000 | CN1245504A Peptides and compounds that bind to receptor |
| 02/23/2000 | CN1245503A Oil bodies and associated proteins as affinity matrices |
| 02/23/2000 | CN1245502A DNA encoding lepidopteran-active delta-endotoxins and its use |
| 02/23/2000 | CN1245393A Hypersensitive response induced resistance in plants by seed treatment |
| 02/23/2000 | CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B |
| 02/23/2000 | CN1049663C Human progonoma necrosis factor |
| 02/22/2000 | US6029114 Molecular modelling of neurotrophin-receptor binding |
| 02/22/2000 | US6028247 Recombinant dna from safflower or brassica; for modification of fatty acid composition in plants |
| 02/22/2000 | US6028246 Transformed plant cell, comprising in its genome, a dna sequence encoding a crystal protein which is toxic to lepidoptera |
| 02/22/2000 | US6028245 Having murine double minute 2 gene inserted into genome and linked to promoter for expression in skin for phenotype resembling ichthyosis vulgaris; for screening treatments |
| 02/22/2000 | US6028244 Transgenic animal whose genome comprises a homozygous disruption an endogenous g protein gene; for screening agents |
| 02/22/2000 | US6028186 High affinity nucleic acid ligands of cytokines |
| 02/22/2000 | US6028185 Nucleic acid markers for apospory-specific genomic region |
| 02/22/2000 | US6028184 For transgenic cells; for diagnosis of hypoglycemia, psychological and brain disorders; antidiabetic/hyperglycemic agents |
| 02/22/2000 | US6028177 Methods of detecting single-chain forms of the glycoprotein hormone quartet |
| 02/22/2000 | US6028176 High-affinity interleukin-4 muteins |
| 02/22/2000 | US6028175 Amino acid sequence; for pharmacology and screening of agonists and antagonists |
| 02/22/2000 | US6028174 Method of diagnosing and treating gliomas |
| 02/22/2000 | US6028173 Amino acid sequence of polypeptide involved in axon outgrowth |
| 02/22/2000 | US6028171 Class I MHC modulation of surface receptor activity |
| 02/22/2000 | US6028170 Analogs of hirudin |
| 02/22/2000 | US6028169 Chemokine β-6 antagonists |
| 02/22/2000 | US6028168 Lanthionine bridged peptides |
| 02/22/2000 | US6028058 Methods and compositions for regulating nuclear trafficking of proteins |
| 02/22/2000 | US6028055 Use in treatment or prophylaxis of various pathological conditions associated with water or electrolyte imbalance |
| 02/22/2000 | US6028053 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 02/22/2000 | US6028049 Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis |
| 02/22/2000 | US6027935 Gene up-regulated in regenerating liver |
| 02/22/2000 | US6027934 Nucleic acid and vectors encoding an immunodominant fragment of a unique protein antigen originally derived from trypanosoma brucei rhodesiense organisms can induce immunoprotection such as against trypanosomes, leishmania |
| 02/22/2000 | US6027933 Surface expression libraries of heteromeric receptors |
| 02/22/2000 | US6027931 Adeno-associated virus (aav) helper functions that produce low amounts of the long form of aav rep (replication) proteins, resulting in high-efficiency production of recombinant aav |
| 02/22/2000 | US6027927 Human trk receptors and neurotrophic factor inhibitors |
| 02/22/2000 | US6027924 Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof |
| 02/22/2000 | US6027922 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| 02/22/2000 | US6027921 Chimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteins |
| 02/22/2000 | US6027920 System for protein expression and secretion especially in corynebacteria |
| 02/22/2000 | US6027919 BMP-12 and BMP-13 proteins and DNA encoding them |
| 02/22/2000 | US6027917 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
| 02/22/2000 | US6027916 Galectin 9 and 10SV Polynucleotides |
| 02/22/2000 | US6027914 Cytokine response (cr) genes |
| 02/22/2000 | US6027912 Gene encoding an invertebrate alpha1 calcium channel subunit |
| 02/22/2000 | US6027910 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |